These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 8028751
1. [The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma]. Michetti G, Bamberga M, Pugliese C, Ori Belometti M, Arnone P, Minio A, Ciaravino G, Villa R, Alesina R, Cottini M. Minerva Med; 1994 May; 85(5):231-6. PubMed ID: 8028751 [Abstract] [Full Text] [Related]
2. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid. Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, Dema A, Kotsovoulou V, Pavlidis N. Anticancer Res; 1991 May; 11(6):2107-10. PubMed ID: 1663720 [Abstract] [Full Text] [Related]
3. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [Abstract] [Full Text] [Related]
4. Evaluation of neuron-specific enolase, tissue polypeptide antigen, and carcinoembryonic antigen as markers for staging and monitoring response to therapy of lung cancer. Spinazzi A, Soresi E, Boffi R, Nonis A, Noseda A, Cobelli S, Scanni A. Cancer Detect Prev; 1994 Sep; 18(3):209-20. PubMed ID: 8076383 [Abstract] [Full Text] [Related]
5. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N. Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [Abstract] [Full Text] [Related]
6. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung. Aroney RS, Dermody WC, Aldenderfer P, Parsons P, McNitt K, Marangos PJ, Whitacre MY, Ruddon RW, Wiernik PH, Aisner J. Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508 [Abstract] [Full Text] [Related]
9. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC. Muley T, Dienemann H, Ebert W. Anticancer Res; 2003 Jun; 23(5b):4085-93. PubMed ID: 14666606 [Abstract] [Full Text] [Related]
10. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K. Anticancer Res; 2000 Jun; 20(3B):2177-80. PubMed ID: 10928173 [Abstract] [Full Text] [Related]
11. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Fukai R, Sakao Y, Sakuraba M, Oh S, Shiomi K, Sonobe S, Saitoh Y, Miyamoto H. Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308 [Abstract] [Full Text] [Related]
12. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)]. Kawahara M, Furuse K, Arai R, Tsuruta M, Kodama N, Hayashi S, Kiyota M, Kubota K, Mori T, Yamamoto S. Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253 [Abstract] [Full Text] [Related]
13. [Prognostic factors in patients with small cell lung cancer]. Song LH, Song XR, Zhang XQ, Qi JL, Li XJ, Tian H, Bu B. Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):413-6. PubMed ID: 15355646 [Abstract] [Full Text] [Related]
14. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer. Buccheri G, Ferrigno D. J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793 [Abstract] [Full Text] [Related]
15. [Level of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of small cell lung cancer patients: correlation with performance status, disease extent and prognosis]. Szturmowicz M, Rogińska E, Roszkowski K, Kwiek S, Filipecki S, Rowińska-Zakrzewska E. Pneumonol Alergol Pol; 1993 Nov; 61(9-10):467-73. PubMed ID: 8111322 [Abstract] [Full Text] [Related]
16. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer. Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M. Cancer; 2006 Dec 15; 107(12):2842-9. PubMed ID: 17103443 [Abstract] [Full Text] [Related]
17. [Clinical significance of serum carcinoembryonic antigen in small cell lung cancer patients]. Hino M, Ogasawara H, Yoshii A, Yoneda S, Noguchi Y, Sakai H, Yoshida K. Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Feb 15; 30(2):278-84. PubMed ID: 1318435 [Abstract] [Full Text] [Related]
18. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer. Nitta T, Fukuoka M, Masuda N, Kusunoki Y, Matsui K, Kudoh S, Hirashima T, Yana T, Ito K, Takada M. Jpn J Clin Oncol; 1995 Oct 15; 25(5):179-83. PubMed ID: 7474404 [Abstract] [Full Text] [Related]
19. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer]. Pan QR, Zhang X, Xu ZF, Zheng S. Ai Zheng; 2002 Feb 15; 21(2):196-9. PubMed ID: 12479076 [Abstract] [Full Text] [Related]
20. Serum pseudouridine as a biochemical marker in small cell lung cancer. Tamura S, Fujioka H, Nakano T, Hada T, Higashino K. Cancer Res; 1987 Nov 15; 47(22):6138-41. PubMed ID: 2822241 [Abstract] [Full Text] [Related] Page: [Next] [New Search]